Secţiunea 2 - Evaluare şi diagnostic - Ghid din 2019 privind operaţia cezariană

M.Of. 738 bis

În vigoare

Versiune de la: 10 Septembrie 2019

SECŢIUNEA 2:Evaluare şi diagnostic

1.Neilson, JP; Lavender, T; Quenby, S; Wray, S (2003). "Obstructed labour". British Medical Bulletin. 67: 191-204. doi:10.1093/bmb/ldg018. PMID 14711764

2.Hofmeyr, G.J (2004-05-19). "Obstructed labor: using better technologies to reduce mortality". International Journal of Gynecology & Obstetrics. 85: S62-S72. doi:10.1016/j.ijgo.2004.01.011. ISSN 0020-7292.

3.Carmen Dolea, Carla AbouZahr (July 2003). "Global burden of obstructed labour in the year 2000" (PDF). Evidence and Information for Policy (EIP), World Health Organization.

4.Ioan Munteanu. Tratat de obstetrica 2000

5.Van der, Vange N, Weverling, GJ, Ketting, BW, et al. The prognosis of cervical cancer associated with pregnancy: a matched cohort study. Obstet Gynecol 1995; 85:1022.

6.Economos, K, Veridiano, NP, Delke, I, et al. Abnormal cervical cytology in pregnancy: A 17-year experience. Obstet Gynecol 1993; 81:915.

7.Takushi, M, Moromizato, H, Sakumoto, K, Kanazawa, K. Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. Gynecol Oncol 2002; 87:185.

8.Sevin, BU, Nadji, M, Averette, HE, et al. Microinvasive carcinoma of the cervix. Cancer 1992; 70:2121.

9.Sood, AK, Sorosky, JI, Krogman, S, et al. Surgical management of cervical cancer complicating pregnancy: a case-control study. Gynecol Oncol 1996; 63:294.

10.Hannigan, EV, Whitehouse HH, 3rd, Atkinson, WD, Becker, SN. Cone biopsy during pregnancy. Obstet Gynecol 1982; 60:450

11.Schorge, JO, Lee, KR, Sheets, EE. Prospective management of stage IA1 cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report. Gynecol Oncol 2000; 78:217.

12.Committee on Practice Bulletins-Gynecology. Diagnosis and treatment of cervical carcinomas, number 35, May 2002. Obstet Gynecol 2002; 99:855.

13._

14.Penn, Z, Ghaem-Maghami, S. Indications for caesarean section. Best Pract Res Clin Obstet Gynaecol 2001; 15:1.

15.Zanardo, V, Padovani, E, Pittini, C, et al. The influence of timing of elective cesarean section on risk of neonatal pneumothorax. J Pediatr 2007; 150:252.

16.McKenna D, ester Jr, elective cesaerean delivery for whomen with previous anal sphincter rupture. Am J Obstet Gynecol, 2003. Nov; 189 95);1251-6

17.Kriplani A, relan S, Misra NK, Mehta VS, Takkar D, Ruptured intraceranial aneurysm complicating pregnancy. Int J Gynaecol Obstet 1995, feb; 48(2):201-6

18.Piotin M, Souza Filho Cb, Moret J, endovascular treatment of acutely ruptured intracranial aneurysm in pregnancy. Am J Obstet Gynecol 2001. Nov; 185(5):1261-2

19.Brisman JL, Soliman E, 2007. Cerebral aneurysm. eMedicine, topic=3468

20.Nienaber C, Von Kodolitsch Y, Therapeutic management of pacients with Marfan syndrom. Foscus on cardiovascular involvment. Cardiol Rev, 1999 Nov-Dec; 7(6):332-41

21.Keskin H, Mungan T, Aktepe-keskin E, Marfan syndrom in pregnancy: A case report, Ann saudi Med, 2002

22.Hwa J, Richards Jg, Huanhg H, mcKay D, The natural history of aortic dilatation in Marfan Syndrome. Med J Aust, 1993. Apr 19;158 (8);558-62

23.Pyeritz R, maternal and fetal complications of pregnancy in the Marfan syndrom. Am J Med, 1981. Nov;71

24.Sakala Ep, Harding MD, Ehlers-Danlos syndrom type III and pregnancy - a case report, J reprod med 1991

25.Lurie S, Manor M, Hagay Zj, The threat of type iv Ehlers-Danlos syndrome on maternal well being during pregnancy 1998

26.Sunness Js, Pregnancy and retinal disease. In: Sj Ryan, Ap Schachat, RBM. retina. second ed. St Louis, Mosby-1994

27.Sunnes Js. The pregnanat women's eye. surv Ophthalmol 1988 32 (4): 219-238

28.Fastenberg DM, Ober RR, Central serous choroidopathy in pregnancy. Aech Ophthalmol 1999

29.Quintero N, Duenas Diez JL, Bedoya Bergua C, Taboada Montes C, Padillo JP. The use of the radiopelvimetria previously to the induction of labor in primigravidas. Journal of Maternal-Fetal and Neonatal Medicine 2010

30.Pattinson RE. Pelvimetry for fetal cephalic presentations at term. Cochrane Database Syst Rev 2001;(3).

31.Royal College of Obstetricians and Gynaecologists. Pelvimetry. Guideline No. 14. London: RCOG; 2001.

32.Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit. The Use of Electronic Fetal Monitoring: The Use and Interpretation of Cardiotocography in Intrapartum Fetal Monitoring. London: RCOG Press; 2001. Evidence-based Clinical Guideline No. 8.

33.Hall, DR, Odendaal, HJ, Steyn, DW, Grive, D. Urinary protein excretion and expectant management of early onset, severe preeclampsia. Int J Gynaecol Obstet 2002; 77:1.

34.Chammas, MF, Nguyen, TM, Li, MA, et al. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?. Am J Obstet Gynecol 2000; 183:853.

35.Chari, RS, Friedman, SA, O'Brien, JM, Sibai, BM. Daily antenatal testing in women with severe preeclampsia. Am J Obstet Gynecol 1995; 173:1207.

36.Hall, DR, Odendaal, HJ, Steyn, DW, Grove, D. Expectant management of early onset, severe preeclampsia: maternal outcome. BJOG 2000; 107:1252.

37.Duley L. The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology. 2009 Jun;33(3):130-137.

38.Management of Twin Pregnancies (Part I) 2000. Society of Obstetricians and Gynaecologists of Canada. www.gfmer.ch/Guidelines/Pregnancy_newborn/Multiple_pregnancy.html

39.Danforth's Obstetrics and Gynecology sixth edition, 1990; cap. Multiple pregnancy; pg. 381-402

40.John E. Turrentine, MD - Clinical Protocols in Obstetrics and Gynecology -second edition 2003 The Parthenon Publishing Group pg. 327, 332-333l

41.Williams Obstetrics 23st Ed, 2000

42.Steven Gable, Jennifer Niebyl, joe leigh simpson. Obstetrics, Normal and problem pregnancies 2007

43.Royal College of Obstetricians and Gynaecologists. Placenta Praevia and Placenta Accreta Diagnostic and management. Guideline No. 27

44.Ghourab S. Third trimester transvaginal ultrasonography in placenta praevia: does the shape of the lower placental edge predict clinical outcome? Ultrasoun Obstet Gynecol 2001;18:103-8.

45.Oppenheimer, LW, Farine, D, Ritchie, JW, et al. What is a low-lying placenta?. Am J Obstet Gynecol 1991;165:1036.

46.Dawson, WB, Dumas, MD, Romano, WM, et al. Translabial ultrasonography and placenta previa: does measurement of the os-placenta distance predict outcome?. J Ultrasound Med 1996; 15:441.

47.Bhide, A, Prefumo, F, Moore, J, et al. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG 2003; 110:860.

48.Oyelese, Y, Smulian, JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006; 107:927.

49.Cunningham FG, Williams JW. Obstetrics 19th edition. Placenta Praevia pag.836-40.

50.Kayem G, Pannier E, Goffinet F, Grange G, Cabrol D. Fertility after conservative treatment of placenta accreta. Fertil Steril 2002;78:637-8.

51.Courbiere B, Bretelle F, Porcu G, Gamere M, Blanc B. Conservative treatment of placenta acccreta. J Gynecol Obstet Biol Reprod 2003;32;549-54.

52.Clement D, Hayem G, Cabrol D. Conservative treatment of placent percreta: a safe alternative. Eur J Obstet Gynecol Reprod Biol 2004;114:108-9.

53.Butt K, Gagnon A, Delisle MF. Failure to methotrxate and internal iliac ballon catheterization to manage placenta percreta. Obstet Gynecol 2002;99:981-2.

54.Dinkel HP, Durig P, Schnatterbeck P, Triller J. Percutaneous treatment of placenta percreta using coil embolisation. J Endovasc Ther 2003;10:158-62.

55.Oyelee Y, Simulian JC, Placenta praevia, placenta accreta and vasa praevia. Obstet Gynecol 2006 Apr; 107(4): 927-41

56.Lijoi A, Brady J, Vasa praevia diagnosis and management. J Am Board Fam Pract 2003 Nov-Dec; 16(6):543-8

57.Neilson JP. Interventions for treating placental abruption (Cochrane Rewiew). The Cochrane Library 2006, Issue 3

58.Merenstein GB, Weisman LE. Premature rupture of the membranes: neonatal consequences. Semin Perinatol1996; 20:375-80.

59.American College of Obstetricians and Gynecologists. Premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. ACOG practice bulletin no. 1. Int J Gynaecol Obstet 1998; 63:75-84.

60.Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla J-L, Delfraissy JF, et al. Perinatal HIV-1 transmission. Interaction between zidovudine prophylaxis and mode of delivery in the french perinatal cohort. JAMA 1998;280:55-60.

61.Duong T, Ades AE, Gibb DM, Tookey PA, Masters J. Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data. BMJ 1999;319:1227-9.

62.Health Protection Agency. Renewing the Focus: HIV and other Sexually Transmitted Infections in the United Kingdom in 2002 Annual Report, November 2003. www.hpa.org.uk/infections/topics_az/hiv_and_sti/publications/annual2003/annual2003.htm

63.Rodriguez EJ, Spann C, Jamieson D, Lindsay M. Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women. Am J Obstet Gynecol 2001;184:1108-11.

64.Maiques-Montesinos V, Cervera-Sanchez J, Bellver-Pradas J, Abad-Carrascosa A, Serra-Serra V. Post-cesarean section morbidity in HIV-positive women. Acta Obstet Gynecol Scand 1999;78:789-92.

65.Urbani G, de Vries MM, Cronje HS, Niemand I, Bam RH, Beyer E. Complications associated with cesarean section in HIV-infected patients. Int J Obstet Gynaecol Obstet 2001;74:9-15.

66.Ratcliffe J, Ades AE, Gibb D, Sculpher MJ, Briggs AH. Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS 1998;12:1381-8.

67.Mrus JM, Goldie SJ, Weinstein MC, Tsevat J. The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy. AIDS 2000;14:2543-52.

68.Halpern MT, Read JS, Ganoczy DA, Harris DR. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1. AIDS 2000;14:691-700.

69.Chen KT, Sell RL, Tuomala RE. Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women (1). Obstet Gynecol 2001;97:161-8.

70.Derso A, Boxall EH, Tarlow MJ, Flewett TH. Transmission of HBsAg from mother to infant in four ethnic groups. BMJ 1978;1(6118):949-52.

71.Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet 1984;1:921-6.

72.Xu Z-Y, Liu C-B, Francis DP. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics 1985;76:713-18.

73.Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977;105:94-8.

74.Lee SD, Tsai YT, Wu TC, Lo KJ, Wu JC, Yang ZL. Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1998;833-4.

75.Pembrey L, Newell ML, Tovo PA. Hepatitis C virus infection in pregnant women and their children. Italian Journal of Gynaecology and Obstetrics 2000;12:21-8.

76.Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, et al. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission. Lancet 2000;356:904-7.

77.European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG 2001;108:371-7.

78.Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.

79.Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-52.

80.Royal College of Obstetricians and Gynaecologists. Management of genital herpes in pregnancy. Guideline No. 30. London: RCOG Press; 2002.

81.Brocklehurst P, Carney O, Ross E, Mindel A. The management of recurrent genital herpes infection in pregnancy: a postal survey of obstetric practice. Br J Obstet Gynaecol 1995;102:791-7.

82.Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex infections. N Engl J Med 1987;316:240-4.

83.Catalano PM, Merritt AO, Mead PB. Incidence of genital herpes simplex virus at the time of delivery in women with known risk factors. Am J Obstet Gynecol 1991;164:1303-6.

84.van Everdingen JJ, Peeters MF, ten Have P. Neonatal herpes policy in The Netherlands. Five years after a consensus conference. J Perinat Med 1993;21:371-5.

85.Arvin AM, Hensleigh PA, Prober CG, Au DS, Yasukawa LL, Wittek AE, et al. Failure of antepartum maternal cultures to predict the infants risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986;315:796-800.

86.Sakala EP, Andree I. Optimal route of delivery for meningomyelocele. Obstet Gynecol Surv. Apr 1990;45(4):209-12.

87.Preis K, Swiatkowska-Freund M, Janczewska I. Spina bifida--a follow-up study of neonates born from 1991 to 2001. J Perinat Med. 2005;33(4):353-6.

88.Luthy DA, Wardinsky T, Shurtleff DB, et al. Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally. N Engl J Med. Mar 7 1991;324(10):662-6.

89.How HY, Harris BJ, Pietrantoni M, et al. Is vaginal delivery preferable to elective cesarean delivery in fetuses with a known ventral wall defect? Am J Obstet Gynecol. Jun 2000;182(6):1527-34.

90.Salihu HM, Emusu D, Aliyu ZY, et al. Mode of delivery and neonatal survival of infants with isolated gastroschisis. Obstet Gynecol. Oct 2004;104(4):678-83.

91.Puligandla PS, Janvier A, Flageole H, Bouchard S, Laberge JM. Routine cesarean delivery does not improve the outcome of infants with gastroschisis. J Pediatr Surg. May 2004;39(5):742-5.

92.ACOG Committee Opinion No. 340. Mode of term singleton breech delivery. Obstet Gynecol. Joule 2006;108(1):235-7

93.State-of-the-Science Conference Statement Cesarean Delivery on Maternal Request 27-29 March 2006. NIH. Available at http://consensus.nih.gov/2006/2006CesareanSOS027main.htm.

94.Schenker JG, Cain JM. FIGO Committee Report. FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet. Mar 1999;64(3):317-22.

95.Lee YM, D'Alton ME. Cesarean delivery on maternal request: maternal and neonatal complications. Curr Opin Obstet Gynecol. Dec 2008;20(6):597-601Kroll L, Twohey L, Daubeney PE, Lynch D, Ducker DA. Risk factors at delivery and the need for skilled resuscitation. Eur J Obstet Gynecol Reprod Biol 1994;55:175-7.

96.Eidelman AI, Schimmel MS, Bromiker R, Hammerman C. Pediatric coverage of the delivery room: an analysis of manpowerutilization. Journal of Perinatology 1998;18:131-4.

97.Brass LM, Pavlakis SG, De Vivo D et. al: Transcranial Doppler measurements of the middle cerebral artery.Effect of hematocrit. Strike 1988; 19: 1466-1469.

98.Mari G, Adrignolo A, Abuhamad AZ, et. al: Diagnosis of fetal anemia with Doppler ultrasound in pregnancy complicated by maternal blood group immunization. Ultrasound Obstet Gynecol 1995; 5: 400-405.

99.Ronsmans C, De Brouwere V, Dubourg D, et al. Measuring the need for life-saving obstetric surgery in developing countries. BJOG. 2004;111:1027-1030. doi: 10.1111/j.1471-0528.2004.00247.

100.Vyas S, Nicolaides KH, Campbell s: Doppler examination of the middle cerebral artery in anemic fetuses. AmJ Obstet Gynecol 1990; 162: 1066-1068.

101.Johnson MJ, Kramer WB, Alger LS, et. al: Middle cerebral artery peak velocity and fetal anemia. 17th Annual meeting of Society of Perinatal Obstetricians, Anaheim, CA, Jan 22-25, 1997.

102.Sparic R, Malvasi A, Kadija S, Babovic I, Nejkovic L, Tinelli A. Cesarean myomectomy trends and controversies: an appraisal.J Matern Fetal Neonatal Med. 2017 May;30(9):1114-1123.

103.Pergialiotis V, Sinanidis I, Louloudis IE, Vichos T, Perrea DN. Perioperative Complications of Cesarean Delivery Myomectomy: A Meta-analysis.Doumouchtsis SKObstet Gynecol. 2017 Dec;130(6):1295-1303.

104.Venturella R, Quaresima P, Micieli M, Rania E, Palumbo A, Visconti F, Zullo F, Di Carlo C. Non-obstetrical indications for cesarean section: a state-of-the-art review.Arch Gynecol Obstet. 2018 Jul;298(1):9-16.

105.Dagenais C, Lewis-Mikhael AM, Grabovac M, Mukerji A, McDonald SD. What is the safest mode of delivery for extremely preterm cephalic/non-cephalic twin pairs? A systematic review and meta-analyses. BMC Pregnancy Childbirth. 2017 Nov 29;17(1):397.

106.Hofmeyr GJ¹, Barrett JF, Crowther CA. Planned caesarean section for women with a twin pregnancy. Cochrane Database Syst Rev. 2015 Dec 19;(12):CD006553.

107.Nilsson C, Lundgren I, Smith V, Vehvilainen-Julkunen K, Nicoletti J, Devane D, Bernloehr A, van Limbeek E, Lalor J, Begley C. Women-centred interventions to increase vaginal birth after caesarean section (VBAC): A systematic review.Midwifery. 2015 Jul;31(7):657-63.

108.Dodd JM, Crowther CA, Grivell RM, Deussen AR. Elective repeat caesarean section versus induction of labour for women with a previous caesarean birth. Cochrane Database Syst Rev. 2014 Dec 19;(12):CD004906.

109.Clarke M, Savage G, Smith V, Daly D, Devane D, Gross MM, Grylka-Baeschlin S, Healy P, Morano S, Nicoletti J, Begley C. Improving the organisation of maternal health service delivery and optimising childbirth by increasing vaginal birth after caesarean section through enhanced women-centred care (OptiBIRTH trial): study protocol for a randomised controlled trial (ISRCTN10612254). Trials. 2015 Nov 30;16:542.

110.West HM, Jozwiak M, Dodd JM.Methods of term labour induction for women with a previous caesarean section. Cochrane Database Syst Rev. 2017 Jun 9;6:CD009792.

111.Clarke M, Savage G, Smith V, Daly D, Devane D, Gross MM, Grylka-Baeschlin S, Healy P, Morano S, Nicoletti J, Begley C. Improving the organisation of maternal health service delivery and optimising childbirth by increasing vaginal birth after caesarean section through enhanced women-centred care (OptiBIRTH trial): study protocol for a randomised controlled trial (ISRCTN10612254). Trials. 2015 Nov 30;16:542.

112.Morris JM, Roberts CL, Bowen JR, Patterson JA, Bond DM, Algert CS, Thornton JG, Crowther CA; PPROMT Collaboration. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016 Jan 30;387(10017):444-

113.Yang M, Qin Q, Fang Q, Jiang L, Nie S. Cesarean section to prevent mother-to-child transmission of hepatitis B virus in China: A meta-analysis. BMC Pregnancy Childbirth.2017 Sep 12;17(1):303.

114.Kennedy CE¹, Yeh PT, Pandey S, Betran AP, Narasimhan M. Elective cesarean section for women living with HIV: a systematic review of risks and benefits. AIDS. 2017 Jul 17;31(11):1579-1591.

115.Livingston EG, Huo Y, Patel K, Tuomala RE, Scott GB, Stek A; P1025 Team of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group. Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025. J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):74-82.

116.Hunter MI et all, Cervical neoplasia in pregnancy: screeningand management of preinvasive disease. Am J Obstet Gyneco!ogy Vol. 199, lssue 1, Pag 3-9, Iulie 2008.

117.Alouini S et al. Cervical cancer complicating pregnancy: of laparoscopic lymphadenectomy GynecologOncology 2008

118.Ishioka S et. All, Outcomes of planned delivery delay in pregnant patients with invasive gynecologic cancer. lnt ernational Journal Clinical Oncology-2009, 321-325

119.Ciortea R, Mihu D. Conduitaobstetricalăînsarcinamultiplă. In: Berceanu C (Ed.). Sarcinamultiplă, Ed. MedicalăUniversitarăCraiova, 2015, 350-373

120.Mathai M, Ambersheth S, George A. Comparison of two transverse abdominal incisions for cesarean delivery. Int J GynecolObstet2002;78:47-9.

121.Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand 2011; 90:140.

122.Ananth CV, Lavery JA, Vintzileos AM, et al. Severe placental abruption: clinical definition and associations with maternal complications. Am J ObstetGynecol 2016; 214:272?

123.Royal College of Obstetricians and Gynaecologists. Obtaining Valid Consent. Clinical Governance Advice No 6. London: RCOG; 2008 [www.rcog.org.uk/womens-health/clinical-guidance/obtaining-valid-consent].

124.Royal College of Obstetricians and Gynaecologists. Presenting Information on Risk. Clinical Governance Advice No. 7. London: RCOG; 2008

125.Hager RM, Daltveit AK, Hofoss D, Nilsen ST, Kolaas T, Oian P, et al. Complications of caesarean deliveries: rates and risk factors. Am J ObstetGynecol2004; 190:428-34.

126.National Collaborating Centre for Women's and Children's Health. Caesarean Section. Clinical Guideline. London: RCOG Press; 2004.

127.Royal College of Obstetricians and Gynaecologists. Birth After Previous Caesarean Section. Green-top Guideline No. 45. London: RCOG; February 2007

128.Centers for Disease Control and Prevention. National Center for Health Statistics: vital statistics.Available at: http://www.cdc.gov/nchs

129.Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report 2010;29:1-20:24.

130.Boyle A, Reddy UM. Epidemiology of cesarean delivery. Perinatol2012;36:308-14.

131.Berghella V, Baxter JK, Chauhan SP. Evidence- based surgery for cesarean delivery. Am J ObstetGynecol2005; 193:1607-17.

132.Souza JP et al. Caesarean section without medical indications is associated with an increased risk of adverse short-term maternal outcomes: the 2004-2008 WHO Global Survey on Maternal and Perinatal Health. BMC Med 2010;8:1-10.

133.MacLennan AH, Taylor AW, Wilson DH, Wilson D. The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. Br J Obstet Gynaecol 2000; 107:1460-70.

134.Hiller L, Radley S, Mann CH, Radley SC, Begum G, Pretlove ST, et al. Development and validation of a questionnaire for the assessment of bowel and urinary tract symptoms in women. Br J Obstet Gynaecol 2002;109: 413-23.

135.Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. CJASN. 2007;2:543-549. doi: 10.2215/CJN.03761106.

136.Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. BJOG2002; 109:443-7.

137.Silver RM. Fetal death. Obstet Gynecol 2007; 109:153-67.

138.Van Mensel K, Claerhout F, Debois P, Keirse MJ, Hanssens M. A randomized controlled trial of misoprostol and sulprostone to end pregnancy after fetal death

139.Okuda Y, Kitajima T. Epidural hematoma in a parturient who developed disseminated intravascular coagulation after epidural anesthesia. Reg Anesth Pain Med 2001; 26:383-4.th. Obstet Gynecol Int 2009; 2009:496320.

140.Flenady V, Wilson T. Support for mothers, fathers and families after perinatal death. Cochrane Database Syst Rev 2008 pub2.

141.Saflund K, Sjogren B, Wredling R. The role of caregivers after a stillbirth: views and experiences of parents. Birth 2004;31:132-7.